Editas Medicine Inc (0IFK.L)

Name: Editas Medicine Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Pharmaceuticals

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$24.7M

Net Income

-$5.6M

Operating Margin

-56.7%

Free Cash Flow

-$166M

Debt / Assets

85.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Editas Medicine Inc (0IFK.L).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	24,741,000	7,543,000	3,578,000	4,658,000
Cost of Revenue	0	0	0	0
Gross Profit	24,741,000	7,543,000	3,578,000	4,658,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	11,353,000	12,316,000	12,859,000	13,375,000
Operating Expenses	38,757,000	32,091,000	55,122,000	80,821,000
Operating Income	-14,016,000	-24,548,000	-51,544,000	-76,163,000
Interest Expense	-6,635,000	2,399,000	2,020,000	2,216,000
Income Before Tax	-5,620,000	-25,117,000	-53,235,000	-76,088,000
Income Tax Expense	0	0	0	0
Net Income	-5,620,000	-25,117,000	-53,235,000	-76,088,000
Per Share
EPS	-0.06	-0.28	-0.63	-0.92
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Editas Medicine Inc (0IFK.L).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	40,520,000	32,314,000	78,123,000	19,712,000
Cost of Revenue	0	0	177,651,000	6,337,000
Gross Profit	40,520,000	32,314,000	-99,528,000	13,375,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	49,903,000	71,987,000	69,653,000	70,704,000
Operating Expenses	139,856,000	283,466,000	247,304,000	239,325,000
Operating Income	-99,336,000	-251,152,000	-169,181,000	-225,950,000
Interest Expense	6,171,000	0	0	0
Income Before Tax	-160,060,000	-237,093,000	-153,219,000	-220,432,000
Income Tax Expense	0	0	0	0
Net Income	-160,060,000	-237,093,000	-153,219,000	-220,432,000
Per Share
EPS	-1.80	-2.88	-2.02	-3.21
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Editas Medicine Inc (0IFK.L).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	146,645,000	131,541,000	123,652,000	141,522,000
Short Term Investments	0	138,372,000	199,459,000	202,752,000
Net Receivables	15,176,000	16,266,000	10,187,000	5,145,000
Inventory	0	0	0	0
Total Current Assets	163,895,000	289,315,000	340,829,000	356,754,000
Property Plant Equipment	19,663,000	47,051,000	45,712,000	59,217,000
Goodwill and Intangibles	0	0	0	0
Total Assets	186,534,000	341,589,000	499,153,000	514,321,000
Liabilities
Account Payables	2,605,000	5,493,000	8,269,000	9,511,000
Short Term Debt	11,031,000	14,652,000	24,167,000	11,082,000
Total Current Liabilities	46,246,000	77,225,000	63,217,000	60,110,000
Long Term Debt	65,676,000	20,380,000	24,372,000	0
Total Liabilities	159,246,000	207,315,000	150,056,000	153,641,000
Shareholders Equity
Retained Earnings	-1,628,503,000	-1,468,443,000	-1,231,350,000	-1,078,131,000
Total Shareholders Equity	27,288,000	134,274,000	349,097,000	360,680,000

Balance sheet annual history for Editas Medicine Inc (0IFK.L).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	146,645,000	131,541,000	123,652,000	141,522,000
Short Term Investments	0	138,372,000	199,459,000	202,752,000
Net Receivables	15,176,000	16,266,000	10,187,000	5,145,000
Inventory	0	0	0	0
Total Current Assets	163,895,000	289,315,000	340,829,000	356,754,000
Property Plant Equipment	19,663,000	47,051,000	45,712,000	59,217,000
Goodwill and Intangibles	0	0	0	0
Total Assets	186,534,000	341,589,000	499,153,000	514,321,000
Liabilities
Account Payables	2,605,000	5,493,000	8,269,000	9,511,000
Short Term Debt	11,031,000	14,652,000	24,167,000	11,082,000
Total Current Liabilities	46,246,000	77,225,000	63,217,000	60,110,000
Long Term Debt	65,676,000	20,380,000	24,372,000	0
Total Liabilities	159,246,000	207,315,000	150,056,000	153,641,000
Shareholders Equity
Retained Earnings	-1,628,503,000	-1,468,443,000	-1,231,350,000	-1,078,131,000
Total Shareholders Equity	27,288,000	134,274,000	349,097,000	360,680,000

Cash flow quarterly history for Editas Medicine Inc (0IFK.L).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-160,060,000	-237,093,000	-153,219,000	-220,432,000
Depreciation & Amortization	5,277,000	5,809,000	6,064,000	6,337,000
Stock Based Compensation	10,000,000	21,417,000	19,798,000	29,294,000
Change in Working Capital	-31,229,000	3,450,000	-1,594,000	8,176,000
Operating Cash Flow	-165,241,000	-210,284,000	-132,178,000	-177,349,000
Investing Activities
Capital Expenditure	-607,000	-8,826,000	-4,719,000	-4,118,000
Investments	-607,000	-8,826,000	-4,719,000	-4,118,000
Investing Cash Flow	138,668,000	162,146,000	-3,731,000	114,068,000
Financing Activities
Debt Repayment	-2,872,000	0	0	0
Common Stock Issued/Repurchased	43,342,000	56,027,000	117,079,000	1,284,000
Dividends Paid	0	0	0	0
Financing Cash Flow	40,470,000	56,027,000	118,039,000	1,284,000
Summary
Free Cash Flow	-165,848,000	-219,110,000	-136,897,000	-181,467,000
Net Change in Cash	13,897,000	7,889,000	-17,870,000	-61,997,000

Cash flow annual history for Editas Medicine Inc (0IFK.L).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-160,060,000	-237,093,000	-153,219,000	-220,432,000
Depreciation & Amortization	5,277,000	5,809,000	6,064,000	6,337,000
Stock Based Compensation	10,000,000	21,417,000	19,798,000	29,294,000
Change in Working Capital	-31,229,000	3,450,000	-1,594,000	8,176,000
Operating Cash Flow	-165,241,000	-210,284,000	-132,178,000	-177,349,000
Investing Activities
Capital Expenditure	-607,000	-8,826,000	-4,719,000	-4,118,000
Investments	-607,000	-8,826,000	-4,719,000	-4,118,000
Investing Cash Flow	138,668,000	162,146,000	-3,731,000	114,068,000
Financing Activities
Debt Repayment	-2,872,000	0	0	0
Common Stock Issued/Repurchased	43,342,000	56,027,000	117,079,000	1,284,000
Dividends Paid	0	0	0	0
Financing Cash Flow	40,470,000	56,027,000	118,039,000	1,284,000
Summary
Free Cash Flow	-165,848,000	-219,110,000	-136,897,000	-181,467,000
Net Change in Cash	13,897,000	7,889,000	-17,870,000	-61,997,000